The 41st annual meeting at International Society for Pharmacoepidemiology is approaching. We are pleased to announce our attendance and participation in the upcoming program at the Walter E. Washington Convention Center, Washington DC, USA. […]
We are excited to welcome Isabella Sundelin to the Quantify Research team as our new HR Generalist.
Isabella has a Bachelor of Science in Personnel, Work and Organization from Stockholm University. She began her career in recruitment and has spent the […]
Excited to share that our Danish-Swedish real-world study has been selected for the 𝟐𝟎𝟐𝟓 𝐁𝐞𝐬𝐭 𝐨𝐟 𝐄𝐂𝐓𝐑𝐈𝐌𝐒 slide deck – highlighting it as one of this year’s top abstracts.
The abstract, co-authored by Jonas Banefelt and Mathias Lilja, explores the link […]
Quantify Research is part of the program this year in Barcelona:
-Kelsi Smith (Quantify Research) presents poster P628 on “Sex differences in the association of the melanocortin-1 receptor (MC1R) […]
See what else will change below 👇
The DMP has published updated requirements for the single technology assessment (STA) submission process, applying to both reimbursement and hospital medicines, effective from 1 September 2025.
Key changes:
• 🗓 Companies must notify the DMP of […]
Quantify Research has co-authored a new paper on the health care and productivity costs of narcolepsy, using comprehensive Swedish registry data.
The study matched incident narcolepsy patients to controls by age and sex to […]
Join us at the end of October in Helsinki or remote for an event hosted by VALO and the FinHITS project to explore what’s already been achieved—and what lies ahead.
Our own Emilie Toresson Grip (Quantify’s Head of RWE & Analytics) […]
Last Thursday the Nordic Quantify Research team got together for our annual summer party at Södra Teatern.
Thanks to everyone who attended for a great evening filled with a scavenger hunt, dinner, and […]
📅 Each Monday, we lace up and get moving – it’s lunch run day!
👋 If you spot the team out on the move, give us a wave
[…]
We’re excited to share our latest manuscript “Real-world Utilization of Biologic and targeted Synthetic Disease- Modifying Anti- Rheumatic Drugs in Psoriatic Arthritis and Axial Spondyloarthritis : Insights from Sweden and Germany”” now […]